(19)

(11)

EP 4 770 627 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 23767958.4 (22) Date of filing: 31.08.2023

(51) International Patent Classification (IPC):  A61K 31/198(2006.01) A61K 31/519(2006.01) A61K 45/06(2006.01) A61P 25/02(2006.01) A61K 31/4985(2006.01) A61K 31/53(2006.01) A61P 25/00(2006.01) A61P 25/28(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/519; A61K 31/4985; A61K 31/53; A61K 31/198; A61K 45/06; A61P 25/00; A61P 25/28; A61P 25/02   C-Sets: A61K 31/519, A61K 2300/00; A61K 31/4985, A61K 2300/00; A61K 31/53, A61K 2300/00; A61K 31/198, A61K 2300/00; (86) International application number: PCT/GB2023/052250 (87) International publication number: WO 2025/046207 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (71) Applicant: Future Pharmatech Co., Ltd. Taipei City 105406 (TW)	(72) Inventors: CHAO, Ming Wei Taipei City 105406 (TW) TSENG, Chia Yi Taipei City 105406 (TW) CHEN, Po Tung Taipei City 105406 (TW) (74) Representative: Lavoix  Bayerstraße 83 80335 München 80335 München (DE)